Abstract:Gut microbiota community shift with coronary artery disease (CAD) has been reported in several limited cohorts during the past several years. However, whether the enriched or decreased microbiota taxa with CAD can be reproducible deserves further investigation and validation. In this study, 78 human subjects were recruited. Of these, 19 were diagnosed without stenosis in coronary artery (control group, referred to herein as Ctrl), 14 with stenosis less than 50% (LT50), and 45 with stenosis greater than 50% (GT50). Fecal samples were collected and DNA was extracted to perform 16S rRNA gene sequencing. The operational taxonomic units (OTUs) were analyzed to identify taxa specific to different groups; next, multivariate logistic regression was employed to test whether the defined taxa could independently predict CAD risk. We found that Deltaproteobacteria, Fusobacterium, Bilophila, Actinomyces, and Clostridium XIX were enriched in Ctrl; Prevotellaceae, Parabacteriodes, and Butyricicoccus were enriched in LT50; and Roseburia and Butyricimonas were enriched in GT50. Further analysis revealed that increased populations of Deltaproteobacteria, Fusobacterium, Bilophila, and Desulfovibrionaceae were associated with a 0.26-fold, 0.21-fold, 0.18-fold, and 0.26-fold decreased risk of CAD, respectively (p < 0.05), and an increased Prevotellaceae population was associated with a 5.63-fold increased risk of CAD (p < 0.01). A combination of the 20 microbial taxa achieved an area under the receiver operating characteristic (ROC) curve of higher than 0.88 for all discriminations between LT50 vs Ctrl, GT50 vs Ctrl, LT50 + GT50 vs Ctrl, and GT50 vs Ctrl + LT50. However, the microbial taxa previously reported as enriched in CAD patients or healthy controls could not be observed in our cohort except for Bacteroides. In conclusion, CAD patients showed a different microbial taxa signature than the healthy controls. However, the non-reproducibility of the microbiota taxa enriched in CAD across different cohorts limits the use of this signature in early diagnosis and prevention. Only decreased Bacteroides abundance was found to be a reliable marker to indicate CAD progression.

Faecalibacterium prausnitzii as a potential Antiatherosclerotic microbe

Faecalibacterium prausnitzii Reduces Plasma Lipopolysaccharide and Inhibits Atherosclerosis

Metagenomic analysis of the gut microbiome in atherosclerosis patients identify cross-cohort microbial signatures and potential therapeutic target

Both gut microbiota and cytokines act to atherosclerosis in ApoE -/- mice

A consortium of three-bacteria isolated from human feces inhibits formation of atherosclerotic deposits and lowers lipid levels in a mouse model

The gut microbiome in subclinical atherosclerosis: a population-based multiphenotype analysis

Gut Microbiome and Atherosclerosis: A Mendelian Randomization Study

Characterization of gut microbiota in adults with coronary atherosclerosis

Gut Microbiota Community Shift with Severity of Coronary Artery Disease

Gut microbiota: a superior operator for dietary phytochemicals to improve atherosclerosis

Unlocking Cardioprotective Potential of Gut Microbiome: Exploring Therapeutic Strategies

Gut microbiota from coronary artery disease patients contributes to vascular dysfunction in mice by regulating bile acid metabolism and immune activation

The Gut Microbiome in Atherosclerotic Cardiovascular Disease.

Gut microbiome and metabolites, the future direction of diagnosis and treatment of atherosclerosis?

Probiotic Enterococcus Faecium Attenuated Atherosclerosis by Improving SCFAs Associated with Gut Microbiota in ApoE-/- Mice

Microbiota-derived short-chain fatty acids: Implications for cardiovascular and metabolic disease

Bifidobacterium animalis subsp. lactis F1-7 Alleviates Lipid Accumulation in Atherosclerotic Mice via Modulating Bile Acid Metabolites to Downregulate Intestinal FXR

Butyrate-producing bacteria and the gut-heart axis in atherosclerosis

Causality of the gut microbiome and atherosclerosis-related lipids: a bidirectional Mendelian Randomization study

Fecal microbiota transplantation validates the importance of gut microbiota in an ApoE−/− mouse model of chronic apical periodontitis-induced atherosclerosis

Integrated metagenomics identifies a crucial role for trimethylamine-producing Lachnoclostridium in promoting atherosclerosis